ZA200300075B - Novel aerosol formulation containing a polar fluorinated molecule. - Google Patents

Novel aerosol formulation containing a polar fluorinated molecule. Download PDF

Info

Publication number
ZA200300075B
ZA200300075B ZA200300075A ZA200300075A ZA200300075B ZA 200300075 B ZA200300075 B ZA 200300075B ZA 200300075 A ZA200300075 A ZA 200300075A ZA 200300075 A ZA200300075 A ZA 200300075A ZA 200300075 B ZA200300075 B ZA 200300075B
Authority
ZA
South Africa
Prior art keywords
formulation
hfa
peg
perfluoro
ethyl
Prior art date
Application number
ZA200300075A
Other languages
English (en)
Inventor
Rogueda Philippe
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200300075B publication Critical patent/ZA200300075B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200300075A 2000-07-11 2003-01-03 Novel aerosol formulation containing a polar fluorinated molecule. ZA200300075B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0016876.5A GB0016876D0 (en) 2000-07-11 2000-07-11 Novel formulation

Publications (1)

Publication Number Publication Date
ZA200300075B true ZA200300075B (en) 2004-04-05

Family

ID=9895336

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200300075A ZA200300075B (en) 2000-07-11 2003-01-03 Novel aerosol formulation containing a polar fluorinated molecule.

Country Status (21)

Country Link
US (1) US20030194378A1 (es)
EP (1) EP1303258B1 (es)
JP (1) JP2004502719A (es)
KR (1) KR20030025265A (es)
CN (1) CN1455663A (es)
AT (1) ATE342048T1 (es)
AU (2) AU7286601A (es)
BR (1) BR0112322A (es)
CA (1) CA2415092A1 (es)
CY (1) CY1105913T1 (es)
DE (1) DE60123793T2 (es)
DK (1) DK1303258T3 (es)
ES (1) ES2273864T3 (es)
GB (1) GB0016876D0 (es)
IL (2) IL153726A0 (es)
MX (1) MXPA03000276A (es)
NO (1) NO20030133L (es)
NZ (1) NZ523379A (es)
PT (1) PT1303258E (es)
WO (1) WO2002003958A1 (es)
ZA (1) ZA200300075B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759042A (ja) * 1993-08-13 1995-03-03 Toshiba Corp 画像保管装置
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003047603A2 (en) * 2001-12-04 2003-06-12 Minnesota High-Tech Resources, Llc Breathable gas mixtures to change body temperature
CA2470520A1 (en) 2001-12-21 2003-07-24 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
MXPA04007294A (es) * 2002-02-01 2004-10-29 Astrazeneca Ab Composicion para inhalacion.
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE0203376D0 (sv) * 2002-11-15 2002-11-15 Astrazeneca Ab New process
FR2851166A1 (fr) * 2003-02-13 2004-08-20 D Lab Utilisation d'un liquide volatil a pression atmospherique et a temperature ambiante pour la fabrication de compositions pharmaceutiques et/ou biologiques
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20060188729A1 (en) * 2005-02-22 2006-08-24 Kai-Volker Schubert Washable leather with repellency
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US20090012250A1 (en) * 2007-07-03 2009-01-08 Yu-Chin Lai Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
KR100910848B1 (ko) * 2007-09-13 2009-08-06 재단법인서울대학교산학협력재단 알러지성 비염 치료약물을 유효성분으로 함유하는 비강분무용 마이크로스피어 및 이의 제조방법
US8586007B2 (en) 2007-10-19 2013-11-19 Wayne State University Co-polymer stabilizers for hydrofluoroalkane dispersions
EP2294044B1 (en) * 2008-04-28 2016-07-13 AL.CHI.MI.A. S.r.l. Fluoroalkyloxy alkanes, process for production and uses thereof
EP2459182B1 (en) * 2009-07-30 2017-09-06 University of Zürich Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
CN102574958B (zh) * 2009-10-09 2014-07-16 株式会社吴羽 新的1,1-二氟乙烯共聚物及其制造方法
EP2407150A1 (de) * 2010-07-16 2012-01-18 Justus-Liebig-Universität Gießen Nano- und Mikropolymerpartikel zur Aufrechterhaltung einer niedrigen Oberflächenspannung in der Lunge und zum Schutz des pulmonalen Surfactants
JP6392753B2 (ja) * 2012-07-18 2018-09-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung フッ素化界面活性剤
KR101516057B1 (ko) * 2012-12-07 2015-04-30 가톨릭대학교 산학협력단 폐질환 치료용 흡입 제형 및 이의 제조방법
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
EP3946220A4 (en) * 2019-04-01 2023-04-05 Honeywell International Inc. PERSONAL CARE AEROSOL COMPOSITIONS, METHODS AND DEVICES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557294A (en) * 1967-10-12 1971-01-19 Allied Chem Fluorinated ethers as inhalation convulsants
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US5605882A (en) * 1992-05-28 1997-02-25 E. I. Du Pont De Nemours And Company Azeotrope(like) compositions of pentafluorodimethyl ether and difluoromethane
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
NZ306281A (en) * 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5730894A (en) * 1996-04-16 1998-03-24 E. I. Du Pont De Nemours And Company 1,1,2,2,3,3,4,4-octafluorobutane azeotropic (like) compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DK1014943T3 (da) * 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
IL153726A (en) 2008-07-08
MXPA03000276A (es) 2003-06-06
BR0112322A (pt) 2003-07-08
NO20030133D0 (no) 2003-01-10
DK1303258T3 (da) 2007-01-22
CN1455663A (zh) 2003-11-12
KR20030025265A (ko) 2003-03-28
NZ523379A (en) 2004-06-25
CY1105913T1 (el) 2011-04-06
NO20030133L (no) 2003-02-24
EP1303258A1 (en) 2003-04-23
JP2004502719A (ja) 2004-01-29
AU7286601A (en) 2002-01-21
IL153726A0 (en) 2003-07-06
DE60123793T2 (de) 2007-09-06
GB0016876D0 (en) 2000-08-30
AU2001272866B2 (en) 2005-08-11
ATE342048T1 (de) 2006-11-15
US20030194378A1 (en) 2003-10-16
CA2415092A1 (en) 2002-01-17
DE60123793D1 (de) 2006-11-23
PT1303258E (pt) 2007-01-31
WO2002003958A1 (en) 2002-01-17
EP1303258B1 (en) 2006-10-11
ES2273864T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
AU2001272866B2 (en) Novel aerosol formulation containing a polar fluorinated molecule
AU2001272866A1 (en) Novel aerosol formulation containing a polar fluorinated molecule
ES2358293T3 (es) Formulaciones de aerosol de diisobutirilapomorfina.
EP0777467B1 (en) Aerosol drug formulations containing polyglycolyzed glycerides
JPH07509475A (ja) 医薬
JP2004509159A (ja) 新規なアルカン酸誘導体
EP1492500B1 (en) Formoterol and ciclesonide aerosol formulations
EP1345591B1 (en) Pharmaceutical aerosol formulation
JP2000503673A (ja) クロロフルオロカーボンを含まないモメタゾンフロエートエーロゾルの処方物
RU2795231C2 (ru) Новые частицы носителя для сухих порошковых составов для ингаляции
US20230057979A1 (en) Medicinal compositions for carbon dioxide based metered dose inhalers
EP3829641B1 (en) Novel carrier particles for dry powder formulations for inhalation
KR0175164B1 (ko) 에어로졸 약물 제제
US7185647B2 (en) Determination of smoothness of canisters containing inhalable medicaments
HU211496A9 (en) Aerosol composition and a process for preparing same
Hu Investigation of factors influencing the development of pressurized metered dose inhalers
CA2711292A1 (en) Inhalation drug products, systems and uses
JPH1067655A (ja) 喘息治療用エアゾール剤
MXPA99001786A (es) Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos